Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity - PubMed (original) (raw)
. 1995 Sep 1;155(5):2487-97.
Affiliations
- PMID: 7650379
Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity
R A Vescio et al. J Immunol. 1995.
Abstract
The lg VH region sequence in 48 patients with multiple myeloma (MM) was analyzed to characterize the malignant cell of origin. The sequences were obtained after amplification of bone marrow cDNA by using VH family-specific and CH primers, then compared with either directly sequenced patient germ-line or published VH gen sequences to assay for somatic mutation. Because somatic hypermutation of the VH gene occurs late in B cell development, its presence has been helpful in determining the cell of origin in other B cell malignancies. Overall, a median of 8.2% of the nucleotides had evidence of substitution within each VH gene sequence (range=2.7% to 16.5%), which is more prevalent than in any other reported tumor type. Strong evidence of prior antigenic selection pressure was also evident. The ratio of nucleotide substitutions that resulted in amino acid replacement was significantly higher in the complementarity-determining region than in the framework region (3.25 vs 1.56, respectively; p < 0.00005). No VH gene intraclonal diversity was noted, despite sequencing multiple clones (3-16) from each patient, nor was there evidence of further VH gene somatic mutation over the course of three patients' disease. These findings strongly imply that the malignant clone in MM evolves from a cell late in B cell development.
Similar articles
- Immunoglobulins D and M multiple myeloma variants are heavily mutated.
Juge-Morineau N, Heirman C, Bakkus M, Van Camp B, Malfait R, Harousseau JL, Thielemans K, Bataille R. Juge-Morineau N, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2501-6. Clin Cancer Res. 1997. PMID: 9815653 - Use of the most JH-proximal human Ig H chain V region gene, VH6, in the expressed immune repertoire.
Varade WS, Marin E, Kittelberger AM, Insel RA. Varade WS, et al. J Immunol. 1993 Jun 1;150(11):4985-95. J Immunol. 1993. PMID: 8496600 - [Characterization of the immunoglobulin heavy and light chain variable region sequences from human multiple myeloma cells].
Kiyoi H, Naoe T, Ohno R. Kiyoi H, et al. Nihon Rinsho. 1995 Mar;53(3):592-7. Nihon Rinsho. 1995. PMID: 7699890 Review. Japanese. - Multiple myeloma: new evidence and insights from the immunoglobulin heavy chain gene and phenotypes.
Takishita M, Kosaka M. Takishita M, et al. Leuk Lymphoma. 1995 Nov;19(5-6):395-400. doi: 10.3109/10428199509112196. Leuk Lymphoma. 1995. PMID: 8590838 Review.
Cited by
- Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells.
Falank C, Fairfield H, Reagan MR. Falank C, et al. Front Endocrinol (Lausanne). 2016 Jun 17;7:67. doi: 10.3389/fendo.2016.00067. eCollection 2016. Front Endocrinol (Lausanne). 2016. PMID: 27379019 Free PMC article. Review. - Idiotype-specific T cells in multiple myeloma: targets for an immunotherapeutic intervention?
Yi Q, Osterborg A. Yi Q, et al. Med Oncol. 1996 Mar;13(1):1-7. doi: 10.1007/BF02988835. Med Oncol. 1996. PMID: 8869933 Review. - Can we change the disease biology of multiple myeloma?
Borrello I. Borrello I. Leuk Res. 2012 Nov;36 Suppl 1(0 1):S3-12. doi: 10.1016/S0145-2126(12)70003-6. Leuk Res. 2012. PMID: 23176722 Free PMC article. Review. - Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories.
Gkoliou G, Agathangelidis A, Karakatsoulis G, Lalayanni C, Papalexandri A, Medina A, Genuardi E, Chlichlia K, Hatjiharissi E, Papaioannou M, Terpos E, Jimenez C, Sakellari I, Ferrero S, Ladetto M, Sanz RG, Belessi C, Stamatopoulos K. Gkoliou G, et al. Front Oncol. 2023 Feb 8;13:1123029. doi: 10.3389/fonc.2023.1123029. eCollection 2023. Front Oncol. 2023. PMID: 36845709 Free PMC article. - Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.
Abraham RS, Manske MK, Zuckerman NS, Sohni A, Edelman H, Shahaf G, Timm MM, Dispenzieri A, Gertz MA, Mehr R. Abraham RS, et al. J Clin Immunol. 2007 Jan;27(1):69-87. doi: 10.1007/s10875-006-9056-9. Epub 2006 Dec 28. J Clin Immunol. 2007. PMID: 17192818
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical